Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2064)
All Articles published online
|
Jul 28, 2007 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Hagiwara T, Kato M, Anbo T, Imamura A, Suga T, Uchida T, Fujinaga A, Nakagawa M, Nakagawa S, Shimizu Y, Yamamoto J, Takeda H, Asaka M. Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i28/3836.htm |
| Number | Citing Articles |
| 1 |
Yuko Morino, Mitsushige Sugimoto, Naoyoshi Nagata, Ryota Niikiura, Eri Iwata, Mariko Hamada, Yusuke Kawai, Tatsuhiro Fujimiya, Hironori Takeuchi, Sakae Unezaki, Takashi Kawai. Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.759249
|
| 2 |
Bhupesh Dewan, Nisha Philipose. Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial. Gastroenterology Research and Practice 2011; 2011: 1 doi: 10.1155/2011/640685
|
| 3 |
Bhupesh Dewan, Raghuram Chimata. An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition. World Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(5): 112-118 doi: 10.4292/wjgpt.v1.i5.112
|
| 4 |
Takahiko Kudo, Haruka Fujinami, Takayuki Ando, Jun Nishikawa, Kohei Ogawa, Ayumu Hosokawa, Tadahiro Orihara, Jun Murakami, Terumi Takahara, Toshiro Sugiyama. Comparison of Lafutidine and Rabeprazole in 7‐day Second‐line Amoxicillin‐ and Metronidazole‐Containing Triple Therapy for Helicobacter pylori: A Pilot Study. Helicobacter 2012; 17(4): 277 doi: 10.1111/j.1523-5378.2012.00943.x
|
| 5 |
Nayoung Kim, Soo‐Heon Park, Geom Seog Seo, Sang Woo Lee, Jae Woo Kim, Kwang Jae Lee, Won‐Chang Shin, Tae Nyeun Kim, Moo‐In Park, Jong‐Jae Park, Su Jin Hong, Ki‐Nam Shim, Sang Wook Kim, Yong‐Woon Shin, Young‐Woon Chang, Hoon Jai Chun, Ok‐Jae Lee, Won‐Joong Jeon, Chan‐Guk Park, Chang‐Min Cho, Cheol Hee Park, Sun Young Won, Gin Hyug Lee, Kyung Sik Park, Jeong Eun Shin, Heung Up Kim, Joon Yong Park, Hiun Suk Chae, Geun Am Song, Jae Gyu Kim, Byung Chul Yoon, Sangyong Seol, Hyun Chae Jung, In‐Sik Chung. Lafutidine versus Lansoprazole in Combination with Clarithromycin and Amoxicillin for One versus Two Weeks for Helicobacter pylori Eradication in Korea. Helicobacter 2008; 13(6): 542 doi: 10.1111/j.1523-5378.2008.00648.x
|